Mar 3, 2026 08:06AM
Mar 3, 2026 08:05AM
Feb 23, 2026 08:00AM
Feb 23, 2026 08:00AM
Jan 12, 2026 08:05AM
Jan 12, 2026 08:04AM
Jan 12, 2026 08:00AM Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
Jan 2, 2026 04:06PM
Nov 21, 2025 06:34AM
Nov 12, 2025 09:00AM
Nov 3, 2025 09:04AM
Nov 3, 2025 09:00AM
Sep 3, 2025 06:00PM
Sep 3, 2025 06:00PM Atara Biotherapeutics Announces Changes to Its Board of Directors
Aug 18, 2025 06:25AM
Aug 11, 2025 04:01PM
Jul 24, 2025 08:57AM
Jul 24, 2025 08:00AM
Jul 24, 2025 08:00AM
Jul 15, 2025 08:00AM
Jul 14, 2025 08:01AM Atara Biotherapeutics resubmits tab-cel application to FDA
Jul 14, 2025 08:00AM
May 28, 2025 08:00AM
May 15, 2025 08:35AM
May 5, 2025 05:06PM
Mar 7, 2025 04:01PM
Jan 28, 2025 06:41AM
Jan 21, 2025 03:45PM Atara Biotherapeutics (ATRA) PT Lowered to $5 at Stifel
Jan 21, 2025 07:32AM
Jan 21, 2025 07:30AM
Jan 17, 2025 06:31AM
Jan 16, 2025 08:56AM
Jan 16, 2025 08:35AM
Jan 16, 2025 08:30AM
Nov 12, 2024 04:01PM Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
Aug 12, 2024 05:00PM
Jul 17, 2024 09:01AM
Jul 17, 2024 09:00AM
Jun 21, 2024 04:01PM
May 20, 2024 09:25AM
May 20, 2024 09:25AM
Mar 28, 2024 08:30AM Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress
Feb 29, 2024 09:05AM
Feb 29, 2024 09:05AM
Feb 14, 2024 09:00AM
Feb 14, 2024 09:00AM
Feb 1, 2024 05:50AM
Jan 31, 2024 06:30PM
Dec 20, 2023 04:01PM Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories
Sep 19, 2023 04:01PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All